CAMP4 Therapeutics Corp (NASDAQ: CAMP) on Tuesday, soared 20.83% from the previous trading day, before settling in for the closing price of $1.92. Within the past 52 weeks, CAMP’s price has moved between $1.61 and $12.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 43.14%. The company achieved an average annual earnings per share of 73.62%. With a float of $2.64 million, this company’s outstanding shares have now reached $20.15 million.
Considering the fact that the conglomerate employs 55 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 35.97%, operating margin of -4.68%, and the pretax margin is -49.8%.
CAMP4 Therapeutics Corp (CAMP) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CAMP4 Therapeutics Corp is 86.90%, while institutional ownership is 13.74%. The most recent insider transaction that took place on Oct 15 ’24, was worth 8,399,996. In this transaction 10% Owner of this company bought 763,636 shares at a rate of $11.00, taking the stock ownership to the 763,636 shares. Before that another transaction happened on Oct 15 ’24, when Company’s 10% Owner bought 727,272 for $11.00, making the entire transaction worth $7,999,992. This insider now owns 1,579,885 shares in total.
CAMP4 Therapeutics Corp (CAMP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 73.62% per share during the next fiscal year.
CAMP4 Therapeutics Corp (NASDAQ: CAMP) Trading Performance Indicators
CAMP4 Therapeutics Corp (CAMP) is currently performing well based on its current performance indicators. A quick ratio of 6.92 was reported for the most recent quarter.
Technical Analysis of CAMP4 Therapeutics Corp (CAMP)
Compared to the last year’s volume of 0.19 million, its volume of 2.49 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 66.90%. Additionally, its Average True Range was 0.35.
During the past 100 days, CAMP4 Therapeutics Corp’s (CAMP) raw stochastic average was set at 8.70%, which indicates a significant decrease from 91.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.12% in the past 14 days, which was lower than the 167.94% volatility it showed in the past 100 days.
Nevertheless, the first resistance level for the watch stands at $2.5400 in the near term. At $2.7500, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.1200. If the price goes on to break the first support level at $1.9600, it is likely to go to the next support level at $1.5900. Now, if the price goes above the second support level, the third support stands at $1.3800.
CAMP4 Therapeutics Corp (NASDAQ: CAMP) Key Stats
Market capitalization of the company is 46.77 million based on 20,161K outstanding shares. Right now, sales total 650 K and income totals -51,790 K. The company made 350 K in profit during its latest quarter, and -11,700 K in sales during its previous quarter.
